1. Albert R., Marbach P., Bauer W., Briner U., Fricker G., Bruns C., Ness J. (1993) SDZ CO 611: A highly potent glycated analog of somatostatin with improved oral activity. Life Sci. 53, 517–525
2. Aloj L., Lang L., Jagoda E., Neumann R.D., and Eckelman W.C. (1996) Evaluation of human transferrin radiolabeled with N-succinimidyl 4-[fluorine-18](fluoromethyl) benzoate. J Nucl. Med. 37, 1408–1412
3. Amherdt M., Patel Y.C., Orci L. (1989) Binding and internalization of somatostatine, insulin and glucagon by cultured rat islet cells. J.C1in.Invest. 84 412–417
4. Anderson C.J., Edwards W.B., Pajeaun T.S., Zinn K.R., Welch M.J. (1994) Cu-64-TETA-D-Phe-1octreotide: A positron emitting somatostatin receptor imaging agent with receptor binding and renal clearance similar to In-111-DTPA-D-Phe-1-Octreotide. J.Nucl.Med. 35, 106p (abstr)
5. Angelberger P. Virgolini I. Buchheit O., Egger M., Portner R., Kvaternik H. (1995) Radiopharmaceutical development of 123I-vasoactive intestinal peptide (VIP) for receptor scintigraphy in oncology. J.Label. Compds. Radiopharm. 37, 502–503.